NATICK, Mass., April 26, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2012 Deutsche Bank Healthcare Conference on May 8 in Boston.
Hank Kucheman, chief executive officer, Mike Mahoney, president, and Jeff Capello, executive vice president and chief financial officer, will participate in a 35-minute question and answer session regarding the company beginning at approximately 1:30 p.m. EDT.
A live webcast of the question and answer session will be available via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
This webcast is being hosted by Deutsche Bank. A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.
CONTACT: Steven Campanini 508-652-5740 (office) Media Relations Boston Scientific Corporation email@example.com Sean Wirtjes 508-652-5305 (office) Investor Relations Boston Scientific Corporation Investor_Relations@bsci.com
SOURCE Boston Scientific Corporation